Page 91 - 2019秋季手冊內頁-ebook測試

座長介紹 ABOUT MODERATOR 劉俊煌 (Jin‐Hwang Liu), M.D., Ph.D.
Professor,
Institute of Biopharmaceutical Science, National Yang-Ming University
Attending Physician and Professor,
Division of Hematology and Oncology, CHENG HSIN General Hospital
EDUCATION AND PROFESSIONAL EXPERIENCES:
Ph.D., Institute of Clinical Research, National Yang-Ming University, Taipei, Taiwan, R.O.C. M.D., Medical School, Taipei Medical University
APPOINTMENTS:
2018 Jan-
2015 Nov-2017 Dec
2014 -2015 Nov 2015 Aug-till now 2011 Feb-till now 1995 Apr-2011 Jan
Chief, Division of Hematology and Oncology, Taipei Tzu Chi Hospital Chief, Division of Hematology, Department of Internal Medicine,
Taipei Veterans General Hospital, Taipei
Chief, Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei
Professor, Institute of Biopharmaceutical Sciences, National Yang- Ming University, Taipei
Professor, School of Medicine, National Yang-Ming University, Taipei
Associate professor, School of Medicine, National Yang-Ming University, Taipei, Taiwan, R.O.C.
ACADEMIC EXPERIENCE:
Visiting Scientist Research Fellow
Mar 1993 to Dec 1993 Dec 1988 to Jan 1990
Division of Molecular Pathology, M.D. Anderson Cancer Center, The University of Texas, Houston, USA
Division of Hematology and Oncology, Genesse Hospital, University of Rochester,
New York, USA
RESEARCH INTERESTS:
• Gene and cell therapy, Molecular medicine, Stem cell transplantation
SELECTED PUBLICATIONS: (* corresponder)
1. Chin-Cheng Liu, Jin‐Hwang Liu*, Suh-Chin Wu, Chueh-Chuan Yen, Wei-Shone Chen, Ying-Chieh
Tsai. A Novel E1B-55kD-Deleted Oncolytic Adenovirus Carrying Mutant KRAS-Regulated hdm2 Transgene Exerts Specific Antitumor Efficacy on Colorectal Cancer Cells. Mol Cancer Ther;
92